FDA Inspection 822050 — Merck Sharp & Dohme LLC
The FDA completed an inspection of Merck Sharp & Dohme LLC on February 6, 2013 in West Point, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 6, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- West Point, PA (United States)